GSA Capital Partners LLP Takes Position in Envista Holdings Corporation $NVST

GSA Capital Partners LLP bought a new stake in shares of Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 77,392 shares of the company’s stock, valued at approximately $2,039,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Caitong International Asset Management Co. Ltd increased its stake in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP grew its holdings in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the period. IFP Advisors Inc increased its stake in shares of Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the last quarter.

Analyst Ratings Changes

Several equities research analysts have weighed in on NVST shares. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. upped their price objective on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Piper Sandler reiterated a “neutral” rating and set a $28.00 target price (up from $26.00) on shares of Envista in a report on Thursday, August 6th. Evercore reissued an “outperform” rating and issued a $33.00 target price on shares of Envista in a research note on Thursday, May 7th. Finally, Robert W. Baird set a $34.00 price target on Envista in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, Envista currently has an average rating of “Moderate Buy” and a consensus price target of $29.31.

Envista Stock Performance

Shares of NVST stock opened at $28.05 on Friday. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 48.35, a PEG ratio of 1.34 and a beta of 0.86. The stock has a fifty day moving average of $26.57 and a 200 day moving average of $26.15. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. During the same period in the previous year, the firm earned $0.26 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts expect that Envista Holdings Corporation will post 1.53 earnings per share for the current year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.